SMALL BCDA1 BioCardia, Inc (NASDAQ: BCDA) BioCardia, Inc (NASDAQ: BCDA) is at the forefront of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. The company's innovative phase 3 study, CardiAMP (BCDA-02), is aimed at treating Chronic Myocardial Ischemia, a condition where the heart muscle doesn't receive enough oxygen-rich blood due to the build-up of plaque in the coronary art.. 2023. 2. 12. 이전 1 다음 LIST
